T. Rowe Price Associates’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $204M | Sell |
|
|||||
|
2025
Q2 | $245M | Sell |
|
|||||
|
2025
Q1 | $297M | Buy |
|
|||||
|
2024
Q4 | $330M | Sell |
|
|||||
|
2024
Q3 | $611M | Buy |
|
|||||
|
2024
Q2 | $601M | Sell |
|
|||||
|
2024
Q1 | $519M | Buy |
|
|||||
|
2023
Q4 | $402M | Buy |
|
|||||
|
2023
Q3 | $429M | Sell |
|
|||||
|
2023
Q2 | $588M | Sell |
|
|||||
|
2023
Q1 | $535M | Buy |
|
|||||
|
2022
Q4 | $512M | Buy |
|
|||||
|
2022
Q3 | $430M | Sell |
|
|||||
|
2022
Q2 | $544M | Buy |
|
|||||
|
2022
Q1 | $543M | Buy |
|
|||||
|
2021
Q4 | $615M | Buy |
|
|||||
|
2021
Q3 | $735M | Buy |
|
|||||
|
2021
Q2 | $775M | Sell |
|
|||||
|
2021
Q1 | $714M | Sell |
|
|||||
|
2020
Q4 | $611M | Buy |
|
|||||
|
2020
Q3 | $457M | Buy |
|
|||||
|
2020
Q2 | $323M | Buy |
|
|||||
|
2020
Q1 | $302M | Sell |
|
|||||
|
2019
Q4 | $522M | Sell |
|
|||||
|
2019
Q3 | $392M | Buy |
|
|||||
|
2019
Q2 | $366M | Buy |
|
|||||
|
2019
Q1 | $323M | Buy |
|
|||||
|
2018
Q4 | $330M | Buy |
|
|||||
|
2018
Q3 | $370M | Buy |
|
|||||
|
2018
Q2 | $365M | Buy |
|
|||||
|
2018
Q1 | $343M | Buy |
|
|||||
|
2017
Q4 | $343M | Buy |
|
|||||
|
2017
Q3 | $371M | Buy |
|
|||||
|
2017
Q2 | $289M | Buy |
|
|||||
|
2017
Q1 | $249M | Buy |
|
|||||
|
2016
Q4 | $242M | Buy |
|
|||||
|
2016
Q3 | $240M | Buy |
|
|||||
|
2016
Q2 | $168M | Buy |
|
|||||
|
2016
Q1 | $176M | Buy |
|
|||||
|
2015
Q4 | $177M | Sell |
|
|||||
|
2015
Q3 | $163M | Buy |
|
|||||
|
2015
Q2 | $228M | Buy |
|
|||||
|
2015
Q1 | $208M | Buy |
|
|||||
|
2014
Q4 | $179M | Buy |
|
|||||
|
2014
Q3 | $127M | Sell |
|
|||||
|
2014
Q2 | $171M | Sell |
|
|||||
|
2014
Q1 | $143M | Sell |
|
|||||
|
2013
Q4 | $141M | Buy |
|
|||||
|
2013
Q3 | $86.9M | Buy |
|
|||||
|
2013
Q2 | $77.1M | Buy |
|